...
首页> 外文期刊>European radiology >Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging
【24h】

Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging

机译:第二次射击动脉阶段克服肝硬化成像中的降解肝动脉阶段

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectivesSecond shot arterial phase (SSAP) imaging is an additional arterial phase image obtained by re-injecting a small amount of contrast medium after routine dynamic imaging in gadoxetic acid-enhanced liver MRI. We aimed to evaluate the feasibility and additional value of a SSAP image in gadoxetic acid-enhanced liver MRI.MethodsOne hundred seventy-two patients who underwent SSAP imaging after re-injection of 4mL of contrast material after routine dynamic imaging (original) in gadoxetic acid-enhanced liver MRIs were included. Motion artifacts on arterial phase (AP) images were rated using a 5-point scale and were compared between the original AP images and SSAP images. We evaluated visual detection rates of arterial hypervascularity on the original AP and SSAP images and their subtraction images in patients with hypervascular hepatocellular carcinoma (HCC).ResultsThe motion artifact of the SSAP images was significantly lower than that of the original AP images (mean score, 1.76 vs 2.06; p<0.001). In particular, motion artifacts reduced significantly in the SSAP images of patients with substantial motion artifacts in their original AP images (2.28 vs 3.28; p<0.001). Among the 30 HCC lesions showing hypervascularity on original AP images, only four (4/30, 13.3%) appeared hyperintense on SSAP images. However, subtraction images of SSAP clearly demonstrated arterial hypervascularity in all HCCs.ConclusionSSAP images showed significantly fewer motion artifacts than the original AP images. Subtraction images of SSAP maintained the detectability of arterial hypervascularity, although SSAP images showed poor visual detection of arterial hypervascularity of HCC.Key Points center dot Arterial phase images obtained after a second injection of a small amount of contrast medium (second shot arterial phase [SSAP]) improved motion artifacts compared to the original AP images.center dot The motion artifacts improved significantly in the SSAP images of patients with substantial motion artifacts in their original AP images.center dot Subtraction images of SSAP demonstrated the arterial hypervascularity characteristic of HCC at a level comparable to that of the original AP image.
机译:客观兴奋剂射击动脉相(SSAP)成像是通过在乙酰乙酰酸增强肝MRI中常规动态成像后重新注入少量造影剂而获得的额外动脉相位图像。我们旨在评估钆酸增强肝脏MRI中SSAP图像的可行性和额外价值。在常规动态成像(原始)在乙酰氧基酸中重新注入4mL造影剂后进行SSAP成像后的百七十二患者 - 包括肝脏MRIS。在动脉阶段(AP)图像上的运动伪影使用5点刻度评定,并在原始AP图像和SSAP图像之间进行比较。我们评估了原始AP和SSAP图像上的动脉高血管性的视觉检测率及其减法图像中的高血管肝癌患者(HCC)。SSAP图像的运动伪像显着低于原始AP图像(平均分数, 1.76 vs 2.06; p <0.001)。特别地,在其原始AP图像中大量运动伪影的患者的SSAP图像中显着减少了运动伪影(2.28 Vs 3.28; P <0.001)。在30个HCC病变中显示出在原始AP图像上的高造血体中,只有四(4/30,13.3%)在SSAP图像上出现超敏。然而,SSAP的减法图像在所有HCCS中清楚地显示出动脉高造血结构.ConclusionsSAP图像显示比原始AP图像的运动伪像显着更少。 SSAP的减法图像维持动脉高造血性的可检测性,尽管SSAP图像显示出差的HCC的动脉高血管性的视觉检测差。在第二次注射较少的造影剂中获得后获得的动脉高血肿性相位图像(第二拍动脉阶段[SSAP ])与原始AP图像相比,改进的运动伪影.Center点在其原始AP图像中具有大量运动伪影的患者的SSAP图像中显着改善了运动伪影。SSAP的Center Dot减法图像证明了HCC的动脉高血管性特征与原始AP图像相当的级别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号